Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,808 | 195 | -5,215 | 1,518 | -444 |
| Depreciation Amortization | 960 | 876 | 4,361 | 29 | N/A |
| Income taxes - deferred | -3,255 | 221 | -744 | -118 | -25 |
| Accounts receivable | -3,057 | -2,725 | 809 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,504 | -1,033 | -1,744 | N/A | 70 |
| Other Working Capital | -1,328 | -10,068 | -4,853 | 111 | 41 |
| Other Operating Activity | 8,056 | 4,421 | -1,184 | -3,099 | 263 |
| Operating Cash Flow | $-1,928 | $-8,114 | $-8,569 | $-1,559 | $-95 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1 | 0 | N/A | N/A |
| PPE Investments | -800 | -2,005 | -17 | N/A | N/A |
| Net Acquisitions | N/A | 221 | -6,253 | N/A | N/A |
| Purchase Of Investment | -698 | 1,395 | -585,825 | -722,541 | -131,229 |
| Sale Of Investment | N/A | N/A | 653,554 | 725,189 | 65,780 |
| Other Investing Activity | -684 | 3,273 | -4,201 | -2,923 | -173 |
| Investing Cash Flow | $-2,183 | $2,885 | $57,258 | $-274 | $-65,622 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 62 | -1,215 | 371 | N/A | N/A |
| Debt Issued | 2,000 | N/A | -3,844 | 3,000 | N/A |
| Debt Repayment | -688 | 179 | -1 | N/A | N/A |
| Common Stock Issued | 1,834 | 298 | -33,141 | N/A | 67,854 |
| Other Financing Activity | -288 | 583 | -4,764 | 0 | -2,135 |
| Financing Cash Flow | $2,920 | $-156 | $-41,379 | $3,000 | $65,719 |
| Exchange Rate Effect | -96 | -884 | -82 | N/A | N/A |
| Beginning Cash Position | 2,129 | 8,397 | 1,169 | 2 | N/A |
| End Cash Position | 843 | 2,129 | 8,397 | 1,169 | 2 |
| Net Cash Flow | $-1,286 | $-6,268 | $7,228 | $1,167 | $2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,928 | -8,114 | -8,569 | -1,559 | -95 |
| Capital Expenditure | -1,264 | -2,493 | -3 | N/A | N/A |
| Free Cash Flow | -3,192 | -10,607 | -8,573 | -1,559 | -95 |